UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN C000000254
Receipt No. R000000148
Scientific Title Japan Erythropoietin Treatment Study for Target Hb and Survival
Date of disclosure of the study information 2005/10/01
Last modified on 2019/12/03 11:20:34

No. Disposal Last modified on Item of update
1 Insert 2005/09/30 17:45:23
2 Update 2005/10/11 10:09:31 Last name of contact person
Last name of contact person
Email
3 Update 2006/04/03 17:37:53 Last name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
TEL
Division name
Division name
Division name
Division name
Address
Email1
4 Update 2006/10/17 14:14:58 Results
Results
Other related information
5 Update 2007/03/23 09:44:31 Last name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
6 Update 2007/12/18 15:49:01 Results
Results
7 Update 2008/12/09 18:50:39 TEL
Last name of contact person
Last name of contact person
TEL
Email
TEL
Tel1
Email1

8 Update 2008/12/09 18:57:17 Results
Results
9 Update 2008/12/09 18:59:08
10 Update 2010/01/29 18:01:56 Recruitment status
Results
Results
11 Update 2010/01/29 18:07:02 Division name
TEL
Last name of contact person
Last name of contact person
Division name
Division name
TEL
Division name
Division name
TEL
Tel1
12 Update 2010/06/24 13:57:13 Publication of results
Results
13 Update 2010/06/24 14:20:55 Results
14 Update 2011/02/22 14:45:47 Results
Results
15 Update 2011/12/09 17:44:06 Email
TEL
Post marketing survey by drug manufacture etc., specified by Japanese law.
16 Update 2011/12/09 17:51:01 Results
Results
17 Update 2012/01/30 10:48:42 Recruitment status
Date of closure to data entry
Date analysis concluded
18 Update 2012/12/14 17:38:40 Publication of results
Results
Results
19 Update 2019/12/03 11:20:06 Public title
Scientific Title
20 Update 2019/12/03 11:20:34 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes


Contact us.